What is FibroScan (Liver Elastography)
FibroScan is a non-invasive method for assessing liver stiffness, which aids in diagnosing significant fibrosis and cirrhosis without the need for a liver biopsy. It's particularly useful for conditions like MASLD (Metabolic Associated Steatosis Liver Disease, previously known as NAFLD), viral hepatitis, and alcohol- associated liver disease.
FibroScan can make the process of liver health assessment quicker, easier, and less uncomfortable for patients by reducing the need for invasive, higher-risk liver biopsies. By utilizing transient elastography, we can predict clinically significant portal hypertension and calculate liver stiffness by generating a fibrosis and steatosis score.
With the first FDA-approved treatment for non-cirrhotic MASH (Metabolic Associated Steatohepatitis, previously known as NASH) now available, assessing fibrosis through non-invasive methods like FibroScan becomes even more critical. This treatment provides a valuable option for patients in the earlier stages of liver disease, specifically those with stage F2 to F3 fibrosis, which is where intervention can have the greatest impact in preventing progression to cirrhosis.